GlassScriptPhysician profile
Steven M Smith
NPI 1699763359
$2,081.85
in general payments reported to CMS, 2019-2025
18 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $167 · 2021: $312 · 2022: $363 · 2023: $176 · 2024: $395 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $743.97 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.25 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $243.30 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $226.78 | 2019-2025 | Wainua, Farxiga |
| Biotronik INC. | $105.22 | 2020 | |
| Irhythm Technologies, INC. | $84.39 | 2020-2024 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $69.23 | 2022-2024 | Uptravi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $61.69 | 2023-2024 | Inpefa |
| Daiichi Sankyo INC. | $53.50 | 2023 | Injectafer |
| Pfizer INC. | $52.27 | 2022-2024 | |
| Abbott Laboratories | $35.30 | 2021-2025 | Assurity |
| Medtronic, INC. | $34.34 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $26.22 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $22.10 | 2025 | |
| Abiomed | $19.83 | 2024 | Impella |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.76 | 2024 | Xarelto |
| Cardinal Health 200 LLC | $11.43 | 2019 | |
| Cardiovascular Systems INC. | $8.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.